News about Quality / GMP

Asahi Kasei's Microza Division Earns Gold EcoVadis Rating for Sustainability Excellence

The Gold rating reflects the division’s exceptional performance, particularly in the Environment category, highlighting its continued efforts to reduce ecological impact across manufacturing, supply chains, and value-added operations at the Microza Fuji Plant.

Quality / GMP | 17/07/2025 | By Darshana |  250

LGM Pharma Expands Analytical Testing Services with New Services

These new services, now available at LGM Pharma’s Irvine, CA, facility, offer significant benefits to drug developers, including accelerated turnaround times, enhanced quality control, and cost savings.

Quality / GMP | 16/10/2024 | By Aishwarya |  694

Avery Dennison Rolls Out AD Minidose U9XM to Ensure Authenticity of Pharma Devices

The NXP U9XM chip offers a self-adjust feature to maximize product performance. It provides high read reliability and enhanced performance, even when small tagged items are densely packed in close proximity.

Quality / GMP | 28/08/2024 | By Aishwarya |  604

eXmoor pharma Expands into Full-Service Cell and Gene Therapy CDMO Partner with Opening of GMP Facilities

The 65,000-square-foot facility is designed with the capacity and capability to help scale the next generation of CGTs for human trials and beyond.

Quality / GMP | 18/10/2023 | By Manvi |  1183

Gritgen Therapeutics Launches Operations at Commercial GMP Facility in China

The facility adheres to the global cGMP standards and complies with the regulatory guidelines of authoritative agencies including the NMPA, the FDA and the EMA.

Quality / GMP | 16/10/2023 | By Manvi |  977

Aurisco's Manufacturing Site in China Clears FDA Inspection

Aurisco's Manufacturing Site in China Clears FDA Inspection

Quality / GMP | 24/08/2023 | By Sudeep Soparkar |  872

Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)

Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)

Quality / GMP | 23/08/2023 | By Sudeep Soparkar |  721

Concord Biotech Limited receives EIR for Unit III

Concord Biotech Limited receives EIR for Unit III

Quality / GMP | 23/08/2023 | By Sudeep Soparkar |  1389

Successful FDA inspection at Auriscos manufacturing site in Yangzhou, China

Successful FDA inspection at Aurisco's manufacturing site in Yangzhou, China

Quality / GMP | 16/08/2023 | By Sudeep Soparkar |  826

Lupins Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations

Lupin’s Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations

Quality / GMP | 14/08/2023 | By Sudeep Soparkar |  902